FL
WST icon

Fort LP’s West Pharmaceutical WST Stock Holding History

Fort LP’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,375
Closed -$584K – 310
2021
Q3 		$584K Sell
1,375
-1,110
-45% -$468K 0.19% 219
2021
Q2 		$892K Sell
2,485
-1,709
-41% -$565K 0.26% 191
2021
Q1 		$1.18M Sell
4,194
-383
-8% -$110K 0.33% 178
2020
Q4 		$1.3M Buy
4,577
+1,686
+58% +$473K 0.39% 168
2020
Q3 		$795K Buy
2,891
+1,964
+212% +$520K 0.33% 145
2020
Q2 		$211K Buy
927
+780
+531% +$153K 0.11% 258
2020
Q1 		$22K Buy
+147
New +$22.6K ﹤0.01% 352
2019
Q2 		– Sell
-870
Closed -$96K – 498
2019
Q1 		$96K Buy
+870
New +$90.5K 0.02% 327

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fort LP's WST Position: Q4 2021 in Review

Fort LP sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 1,375 shares — an estimated $584K sold.

Fort LP first reported a position in WST in Q1 2019 and held it in 8 quarters. The position peaked at $1.3M in Q4 2020. 729 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Fort LP reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Fort LP sold 1,375 West Pharmaceutical shares in Q4 2021, an estimated $584K.
  • Fort LP first reported a position in West Pharmaceutical in Q1 2019 and held it in 8 quarters.
  • Fort LP's West Pharmaceutical position peaked at $1.3M in Q4 2020.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Fort LP's 13F filing for Q4 2021, filed 11 Feb 2022.